-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Cantor Fitzgerald Reiterates Overweight Rating for CG Oncology (NASDAQ:CGON)
Cantor Fitzgerald reaffirmed their overweight rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. Cantor Fitzgerald currently has a $75.00 target price on the stock. Several other equities analysts have also recently commented on the stock. TD Cowen started coverage on shares of […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. Cantor Fitzgerald currently has a $75.00 target price on the stock. Several other equities analysts have also recently commented on the stock. TD Cowen started coverage on shares of […]
